Neuro Oncol 2016 Dec 29. Epub 2016 Dec 29.
Department of Epidemiology and Biostatistics, Case Western Reserve University School of Medicine, Cleveland, Ohio (A.S.Z.); Department of Statistical Sciences, Sandia National Laboratories, Albuquerque, New Mexico (A.S.Z.); Case Comprehensive Cancer Center, Case Western Reserve University School of Medicine, Cleveland, Ohio (Q.T.O., L.R., D.M.P., J.S.B.); Central Brain Tumor Registry of the United States (CBTRUS), Hinsdale, Illinois (Q.T.O., C.K., J.S.B.); Brain Tumor and Neuro-Oncology Center, University Hospitals Case Medical Center, Cleveland, Ohio (L.R.); Rose Ella Burkhardt Brain Tumor and Neuro-Oncology Center, Neurological Institute, Cleveland Clinic, Cleveland, Ohio (D.M.P.)
: Complete prevalence proportions illustrate the burden of disease in a population. This study estimates the 2010 complete prevalence of malignant primary brain tumors overall and by Central Brain Tumor Registry of the United States (CBTRUS) histology groups, and compares the brain tumor prevalence estimates to the complete prevalence of other common cancers as determined by the Surveillance, Epidemiology, and End Results Program (SEER) by age at prevalence (2010): children (0-14 y), adolescent and young adult (AYA) (15-39 y), and adult (40+ y).Methods
: Complete prevalence proportions were estimated using a novel regression method extended from the Completeness Index Method, which combines survival and incidence data from multiple sources. Read More